Previous 10 | Next 10 |
2024-05-13 05:03:45 ET Summary Ginkgo Bioworks issued a massive revenue warning, causing shares to drop and raising concerns about the company's future. Q1 revenues were significantly below expectations, with a decline in both the Biosecurity and Cell Engineering segments. The...
A look at the top 10 most actives in the United States Novavax Inc. (NVAX) rose 98.7% to $8.88 on volume of 168,692,127 shares AEye Inc. (LIDR) rose 115.0% to $2.58 on volume of 156,236,079 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 17.3% to $0.7609 on volume of 123,678,040 s...
2024-05-10 11:08:26 ET Summary Ginkgo Bioworks' first quarter earnings were weak, with revenue and guidance falling well short of expectations. The company is shifting its business model away from ownership of IP and participation in downstream value, undermining the bull case. ...
A look at the top 10 most actives in the United States Novavax Inc. (NVAX) rose 128.7% to $10.225 on volume of 69,182,168 shares SoundHound AI Inc. (SOUN) rose 23.9% to $5.885 on volume of 25,153,154 shares Greenwave Technology Solutions Inc. (GWAV) fell 31.9% to $0.0476 on volume of 22,3...
2024-05-10 08:53:47 ET More on Ginkgo Bioworks Holdings Ginkgo Bioworks Holdings, Inc. (DNA) Q1 2024 Earnings Call Transcript Ginkgo Bioworks Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentation Ginkgo Bioworks: Multiple Red Flags Ginkgo Bioworks sur...
2024-05-09 22:18:10 ET Ginkgo Bioworks Holdings, Inc. (DNA) Q1 2024 Earnings Conference Call May 09, 2024 05:30 PM ET Company Participants Megan LeDuc – Manager-Investor Relations Jason Kelly - Co-Founder & Chief Executive Officer Mark Dmytruk - Chief ...
2024-05-09 17:44:19 ET More on Ginkgo Bioworks Holdings Ginkgo Bioworks Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentation Ginkgo Bioworks: Multiple Red Flags Ginkgo Bioworks: More Awful Revenue Guidance Ginkgo Bioworks surges as much as 31%, thoug...
2024-05-09 16:28:40 ET More on Ginkgo Bioworks Holdings Ginkgo Bioworks: Multiple Red Flags Ginkgo Bioworks: More Awful Revenue Guidance Ginkgo Bioworks Holdings, Inc. 2023 Q4 - Results - Earnings Call Presentation Ginkgo Bioworks surges as much as 31%, thoug...
Ginkgo Bioworks Reports First Quarter 2024 Financial Results PR Newswire Ginkgo announces several initiatives to accelerate path to Adjusted EBITDA breakeven by end of 2026 Initiatives include a reduction of $200 million in annualized run-rate operating expenses by...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
News, Short Squeeze, Breakout and More Instantly...
Ginkgo Bioworks Holdings Inc. Class A Company Name:
DNA Stock Symbol:
NYSE Market:
Ginkgo Bioworks Holdings Inc. Class A Website:
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...
Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals PR Newswire Syngenta will leverage Ginkgo's Ag Biologicals capabilities to optimize secondary metabolite production for a pioneering biological solution BASEL, Switzerland ...